Cargando…
Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1
Transcription factors have been considered undruggable, but this paradigm has been recently challenged. DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS–FLI1. Structural details of MTM recognition of DNA, including the FLI1 binding sequence G...
Autores principales: | Hou, Caixia, Weidenbach, Stevi, Cano, Kristin E., Wang, Zhonghua, Mitra, Prithiba, Ivanov, Dmitri N., Rohr, Jürgen, Tsodikov, Oleg V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063001/ https://www.ncbi.nlm.nih.gov/pubmed/27587584 http://dx.doi.org/10.1093/nar/gkw761 |
Ejemplares similares
-
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021) -
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
por: Scott, Daniel, et al.
Publicado: (2011) -
Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences
por: Barceló, Francisca, et al.
Publicado: (2007) -
E. coli elongation factor Tu bound to a GTP analogue displays an open conformation equivalent to the GDP-bound form
por: Johansen, Jesper S, et al.
Publicado: (2018) -
Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue
por: Vizcaíno, Carolina, et al.
Publicado: (2014)